We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GENTERA:BMVGentera SAB de CV Analysis

Data as of 2026-03-15 - not real-time

MX$47.08

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gentera trades at MXN 47.08, comfortably above its 20‑day SMA of 50.53 but below the 50‑day SMA of 49.61, indicating a modest bullish bias while still leaving room for upside. The 14‑day RSI sits at 38.6, suggesting the stock is approaching oversold territory and could rebound toward the resistance level of MXN 54.70. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, yet the overall trend direction is flagged as bullish and volume is increasing. On the valuation side, the price‑to‑earnings ratio of 9.4 is well under the industry average of 16.35, and the DCF‑derived fair value of MXN 9.68 points to a substantial discount, translating to an estimated upside of roughly 13 % versus the current price. The company delivers a solid dividend yield of 3.22 % with a modest payout ratio of 30 %, backed by MXN 17.7 bn of cash and a debt‑to‑equity profile that is effectively neutral. With a market cap of MXN 74.35 bn, low beta (0.272) and a 30‑day volatility of 35 %, Gentera offers a blend of growth (14 % revenue expansion) and value characteristics, supported by strong operating margins and a 24.5 % ROE.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish alignment of SMA 20 above SMA 50 and SMA 200
  • Price near support at MXN 46.27 with increasing volume
  • RSI indicating oversold conditions and potential rebound

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Strong operating margin (33.9 %) and ROE (24.5 %)
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Demographic tailwinds in Mexico and Peru driving micro‑credit demand
  • Consistent dividend policy supporting shareholder returns
  • Robust cash generation and low leverage enhancing financial stability

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin22.53%
P/E Ratio9.4
ROE24.50%
ROA7.50%
P/B Ratio2.1
Op. Cash FlowMX$2.8B
Industry P/E16.4

Technical Analysis

TrendBullish
RSI38.6
SupportMX$46.27
ResistanceMX$54.70
MA 20MX$50.53
MA 50MX$49.61
MA 200MX$45.19
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueMX$9.68
Target PriceMX$53.29
Upside/Downside13.18%
GradeUndervalued
TypeBlend
Dividend Yield3.22%

Risk Assessment

Beta0.65
Volatility35.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.